发明授权
- 专利标题: Biomarker sampling in the context of neuromodulation devices, systems, and methods
-
申请号: US15424575申请日: 2017-02-03
-
公开(公告)号: US10729365B2公开(公告)日: 2020-08-04
- 发明人: Rudy Beasley , Ayala Hezi-Yamit , Michele Lee Silver , Christopher W. Storment
- 申请人: Medtronic Ardian Luxembourg S.a.r.l.
- 申请人地址: LU Luxembourg
- 专利权人: MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L.
- 当前专利权人: MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L.
- 当前专利权人地址: LU Luxembourg
- 主分类号: A61B5/15
- IPC分类号: A61B5/15 ; A61B5/157 ; A61B5/20 ; A61B5/00 ; A61N7/02 ; A61N1/36 ; A61N1/40 ; A61B10/00 ; A61B18/14 ; A61B5/145 ; A61N1/05 ; A61B18/00 ; A61B18/18 ; A61N1/32 ; G01N33/68 ; A61B18/02
摘要:
Methods for treating a patient using therapeutic renal neuromodulation and associated devices, systems, and methods are disclosed herein. One aspect of the present technology is directed to biomarker sampling in the context of neuromodulation devices, systems, and methods. Some embodiments, for example, are directed to catheters, catheter systems, and methods for sampling biomarkers that change in response to neuromodulation. A system can include, for example, an elongated shaft and a neuromodulation and sampling assembly having a neuromodulation and a sampling element.
公开/授权文献
信息查询